A Research Blog

Gayatri SharmaWe speak to Dr Gayatri Sharma, Entrepreneur-in Residence (EiR) with CTeD, to find out how an EiR translates Duke-NUS inventions into commercial applications. 

1.       Tell us what you do as an EiR. 

 My primary role as an EiR is to create commercial value for the Intellectual Properties developed at Duke-NUS. Currently, I am working on developing a business plan around a Laminin platform technology developed at Professor Karl Tryggvason’s laboratory. Laminin-based technology enables us to grow cell types sustainably in large numbers by mimicking the environment of a human body. Some of these cell types include keratinocytes (skin cells), islets (insulin-producing cells) and cardiomyocytes (heart cells). This will address the huge market gap in cell production for therapeutic applications. We have seen great results in animal studies, and my job now is to chart the commercial path for this technology. 

 

Cheryl McCafferyIn this continuing conversation series with members from Centre for Technology & Development (CTeD), let’s find out more from Cheryl McCaffery, Deputy Director of CTeD, about how you can work with CTeD to assess a technology’s potential for commercial development.

CTeD is always happy to hear about new technologies arising from Duke-NUS research programmes. Whenever a new technology is devised (e.g. a new drug or method for diagnosing a disease), you are welcome to speak to us for advice on all aspects of intellectual property protection and commercialisation.

Search

Search form